ViCCY
BehavioralThe intervention group will receive 10 Health Coach sessions of ViCCY over 6-months.
NCT Number: NCT07220798
This RCT design will enroll 256 informal caregivers (spouse/partner or child) of HHC patients with HF/CI and 60 patients with HF and mild to moderate CI (60 dyads). After collecting baseline data, we will block randomize the caregivers 1:1 to the ViCCY intervention or comparator group, stratifying randomization by caregiver sex (male/female), relationship (spouse/partner or child), and race (white/other)- factors known to influence caregiving burden, perceived stress, and receptivity to the intervention. We will encourage caregivers to use their own devices but provide tablet devices with wireless network access if needed. The intervention group will receive 10 sessions of ViCCY over 6 months.
Trial opening soon.
Get Notified18 year–101 year
All sexes
Interventional
Not applicable
Purpose and Specific Aims
Cognitive Impairment (CI) has been reported to be as high as 78% in older adults with Heart Failure (HF). CI markedly increases the risk of adverse HF outcomes such as hospitalization and death, and patients with CI and HF are rarely able to manage without a caregiver. The high level of caregiving demands lead to an increase in stress and strained relationships with caregiving recipients, which can lead to poor coping and decreased mental health among caregivers. This study aims to test a self-care intervention (Virtual Caregiver Coach for You -ViCCY) targeting caregivers to support mental health and explore whether changes in caregiver mental health impacts patient outcomes. We will examine relationship strain as the primary mechanism for improvements in outcomes in patients and caregivers.
Aim 1: Test the efficacy of ViCCY vs. UC in improving outcomes of caregivers of home health care (HHC) patients with HF/CI.
Aim 2: Explore the effect of ViCCY on outcomes in HHC patients with HF/CI. At 6-months we will report differences in mental health measured with the SF-36 and its contributors of depression, anxiety, and somatic HF symptoms between patients whose caregivers are randomized to ViCCY compared to UC.
Aim 3: Describe the mechanisms by which outcomes are achieved.
Overview of Study Design and Methods
This RCT design will enroll 256 informal caregivers (spouse/partner or child) of HHC patients with HF/CI and 60 patients with HF and mild to moderate CI (60 dyads). After collecting baseline data, we will block randomize the caregivers 1:1 to the ViCCY intervention or comparator group, stratifying randomization by caregiver sex (male/female), relationship (spouse/partner or child), and race (white/other)- factors known to influence caregiving burden, perceived stress, and receptivity to the intervention. We will encourage caregivers to use their own devices but provide tablet devices with wireless network access if needed. The intervention group will receive 10 sessions of ViCCY over 6 months.
Participant Recruitment and Data Collection
Participants will be (256) caregivers of community dwelling older adults with HF/CI and 60 dyads (caregivers and patients) with HF and mild to moderate CI.
Data Sources and Analysis
We will use an intent-to-treat approach with the primary outcomes assessed at baseline, 3- and 6-months, and 12-months. Efficacy will be analyzed at 6-months. We will summarize participant characteristics using descriptive statistics. Shapiro-Wilk and Levin's tests will be used to assess distributional assumptions of normality. Mixed effects regression models will be used to assess intervention efficacy. Outcomes will be assessed using pre-post self-reported survey data.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention group will receive 10 Health Coach sessions of ViCCY over 6-months.
Time frame: Baseline, 3- and 6- and 12-months
Mental health is a state of mental well-being that enables people to cope with the stresses of life, realize their abilities, learn well and work well. The SF-36 provides standardized scores and national norms for comparison. The SF-36 is valid in many populations and caregivers. It is one of the common data elements.
Time frame: Baseline, 3- and 6- and 12-months
Behaviors performed to maintain health
Time frame: Baseline, 3- and 6- and 12-months
Demands exceed ability to cope
Time frame: Baseline, 3- and 6- and 12-months
Ability to respond to stressors with appropriate adaptive coping resources.
Time frame: Baseline, 3- and 6- and 12-months
Measure of strain in the dyadic relationship
Time frame: Baseline, 3- and 6- and 12-months
load experienced when caring for a loved one
Time frame: Baseline and 6-months
Measures signs and symptoms of depression.
Time frame: Baseline and 6-months
Measures signs and symptoms of Anxiety.
Time frame: Baseline and 6-months
Measures symptoms of Heart Failure.
Time frame: Baseline and 6-months.
Captures patient Medications and Chronic Conditions.
Contact information is provided by the study sponsor or research team.
Barbara Riegel, PhD, RN
CONTACT
Nicole Onorato, MPH
CONTACT
Visiting Nurse Service of New York
Other
Improving Self-Care of Caregivers of Adults in Homecare With Heart Failure and Cognitive Impairment (iCare4Me Homecare)
Acronym: iCare4Me HC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05431192
Cardiovascular Diseases, Cognition Disorders
Providence, Rhode Island, United States
View Trial DetailsNCT05852509
Behavior, Behavioral Symptoms
Aurora, Colorado, United States
View Trial DetailsNCT00837889
Cardiovascular Diseases, Cognition Disorders
Homburg, Saarland, Germany
View Trial DetailsNCT06601465
Cardiovascular Diseases, Cognition Disorders
Calgary, Alberta, Canada
View Trial Details